ctrl K

Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.37

-0.05 (-12.74%)

At close: May 01, 2025, 3:59 PM

0.38

3.29%

After-hours: May 01, 2025, 07:51 PM EDT

Aspire BioPharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-3.09M	-358.59K	-596.49K
Interest Income	548.68K	n/a	n/a
Pretax Income	-12.54M	-358.59K	-596.49K
Net Income	-12.54M	-359.07K	-597.12K
Selling & General & Admin	3.09M	286.54K	421.18K
Research & Development	n/a	72.05K	175.32K
Other Expenses	n/a	n/a	n/a
Operating Expenses	3.09M	358.59K	596.49K
Interest Expense	891.62K	n/a	n/a
Selling & Marketing Expenses	n/a	39.64K	45.48K
Cost & Expenses	-3.09M	358.59K	596.49K
Income Tax Expense	n/a	481.00	626.00
Shares Outstanding (Basic)	8.24M	45.94M	45.94M
Shares Outstanding (Diluted)	8.24M	45.94M	45.94M
EPS (Basic)	-1.52	-0.01	-0.01
EPS (Diluted)	-1.52	-0.01	-0.01
EBITDA	-11.65M	n/a	-596.49K
EBIT	-11.65M	-358.59K	-596.49K
Depreciation & Amortization	n/a	n/a	n/a